Global Vaccines, Gene Therapy, and Stem Cell Therapy Innovations Report 2021 - ResearchAndMarkets.com

The "Growth Opportunities in Vaccines, Gene Therapy, and Stem Cell Therapy" report has been added to ResearchAndMarkets.com's offering.

This report discusses multiple developments in vaccine technologies, both prophylactic and therapeutic. Most of the innovations highlighted are around influenza, COVID-19, and cancer vaccines. Developments in intranasal delivery, needle-free delivery, and thermostable formulations are also covered.

Advanced technology platforms for scalable manufacturing and plug and play solutions, which can be applied to multiple pathogen serotypes are also discussed. Further, innovations in emerging technologies such as gene therapy for retinal diseases, immunotherapy for cancers, developments in nutraceuticals for cardiovascular protection and cosmeceuticals for skin and hair care and protein-based sweeteners are also profiled in this TOE.

Innovations in Life Sciences, Health & Wellness from

• Altimmune, US
• Serum Institute of India Pvt. Ltd., India
• Nouscom, Switzerland
• Vaxart, US
• Gpn Vacccines, Australia
• Providence Therapeutics, Canada
• 2A Pharma Aps, Denmark
• Vaccitech, UK
• Affinivax, US
• Minervax, Denmark
• Codagenix, US
• Vaxxas Inc., US
• Gradalis Inc., US
• Gotham Therapeutics Corporation, US
• Flavex Naturextrakte Gmbh, Germany
• Enovate Biolife, India
• Gyroscope Therapeutics, UK
• Rinri Therapeutics, UK
• Bharat Biotech International Limited, India
• Sanaria Inc., US
• International Aids Vaccine Initiative, US
• University of Connecticut, US
• Ziccum Ab, Sweden
• Gennova, India

For more information about this report visit https://www.researchandmarkets.com/r/x4oiwa

View source version on businesswire.com: https://www.businesswire.com/news/home/20210809005361/en/